Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
The Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) has been manufacturing and distributing high-quality therapeutics across the Middle East for four decades.
Biotech firm Syntax Bio aims to transform pluripotent stem cells into clinical therapeutics using its CRISPR-based technology platform called Cellgorithm.
Intravitreal injection of jCyte’s proprietary retinal progenitor cells can halt vision loss and potentially restore sight in patients with retinitis pigmentosa, the leading cause of inherited blindness.
